Loading...
XJPX
6312
Market cap117mUSD
Jan 26, Last price  
1,403,645,824.00JPY
Name

Freund Corp

Chart & Performance

D1W1MN
XJPX:6312 chart
P/E
37,263,022.55
P/S
1,015,431.43
EPS
37.67
Div Yield, %
0.00%
Shrs. gr., 5y
0.20%
Rev. gr., 5y
6.88%
Revenues
23.40b
+2.16%
12,943,176,00013,257,904,00015,236,434,00015,236,434,00016,396,939,00017,616,284,00017,424,279,00019,027,633,00019,027,633,00021,164,542,00019,801,447,00018,408,237,00016,772,877,00016,772,877,00016,765,389,00017,632,243,00019,658,519,00022,903,644,00022,903,644,00023,397,731,000
Net income
638m
-16.65%
563,983,000516,992,000608,660,000608,660,000765,356,000787,841,000695,966,000961,129,000961,129,0001,064,266,0001,477,671,000843,575,000381,528,000381,528,000970,595,000543,566,000-538,417,000764,970,000764,970,000637,597,000
CFO
1.75b
-26.10%
457,959,00065,392,0001,219,303,0001,219,303,000740,505,0001,227,300,000822,746,000290,190,000290,190,0003,605,533,000594,047,000435,898,000-27,868,000-27,868,0002,280,475,000701,930,000-196,046,0002,368,327,0002,368,327,0001,750,091,000
Dividend
Feb 27, 202520 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in Tokyo, Japan, in 1964, Freund Corporation is a leading developer, manufacturer, and global supplier of specialized granulation and coating equipment. The company serves the pharmaceutical, food, and chemical industries worldwide. Their comprehensive product portfolio includes a variety of advanced machinery such as granulators, coating systems, dryers, industrial printers, testing and analysis instruments, encapsulators, dust collection units, and drug formulation machines. Additionally, Freund Corporation offers pharmaceutical excipients, food preservation agents, relevant machinery for food preservation, and materials for dietary supplements.
IPO date
Jul 24, 1996
Employees
422
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2025‑022024‑022024‑022023‑022022‑022021‑022020‑022020‑022019‑022018‑022017‑02
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT